1. Cohen A, Jeyaindran S, Kim JY, et al. Treating pulmonary embolism in PacificAsia with direct oral anticoagulants. Thromb Res. 2015; 136(2):196-207.
2. Rosendaal FR. Risk factors for venous thrombotic disease. ThrombHaemost. 1999;82(2):610-619.
3. Pollack CV, Schreiber D, Goldhaber SZ, et al. Clinical characteristics,management, and outcomes of patients diagnosed with acutepulmonary embolism in the emergency department: initial report ofEMPEROR (Multicenter Emergency Medicine Pulmonary Embolism inthe Real World Registry). J Am Coll Cardiol. 2011;57(6):700-706.
4. Nijkeuter M, Hovens MM, Davidson BL, Huisman MV. Resolutionof thromboemboli in patients with acute pulmonary embolism: asystematic review. Chest. 2006;129(1):192-197.
5. Lang IM, Pesavento R, Bonderman D, Yuan JX. Risk factors and basicmechanisms of chronic thromboembolic pulmonary hypertension: acurrent understanding. Eur Respir J. 2013;41(2):462-468.
6. Karabulut H, Gülay MŞ. Serbest radikaller. MAKÜ Sağ Bil Enst Derg.2016;4(1):50-59.
7. Botham KM, Moyes PA. Fizyolojik öneme sahip lipidler. In: GrannerRK, Mayes DK, Rodwell RA, Murray VW, eds. Harper’ın biyokimyası.Barış Kitabevi, 1996.
8. Mühl D, Füredi R, Cristofari J, et al. Evaluation of oxidative stress inthe thrombolysis of pulmonary embolism. J Thromb Thrombolysis.2006;22(3):221-228.
9. Tapson VF, Weinberg AS. Overview of management of intermediate- andhigh-risk pulmonary embolism. Crit Care Clin. 2020;36(3):449-463.
10. Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol.2014;12(8):464-474.
11. Ageno W, Haas S, Weitz JI, et al. Characteristics and management ofpatients with venous thromboembolism: the GARFIELD-VTE registry.Thromb Haemost. 2019;119(2):319-327.
12. Yoshikawa Y, Yamashita Y, Morimoto T, et al. Sex differences in clinicalcharacteristics and outcomes of patients with venous thromboembolism- from the COMMAND VTE registry. Circ J. 2019;83(7):1581-1589.
13. White RH. The epidemiology of venous thromboembolism. Circulation.2003;107:(1)4-8.
14. Özsu S, Özlü T, Bülbül Y. Ulusal verilerle pulmoner tromboemboli.Tuberk Toraks. 2009;57(4):466-482.
15. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponinsin acute pulmonary embolism: a meta-analysis. Circulation. 2007;116(4):427-433.
16. Lankeit M, Jiménez D, Kostrubiec M, et al. Predictive value of thehigh-sensitivity troponin t assay and the simplified pulmonaryembolism severity index in hemodynamically stable patients withacute pulmonary embolism: a prospective validation study. Circulation.2011;124(24):2716-2724.
17. Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brainnatriuretic peptide in acute pulmonary embolism. Circulation.2003;107(20):2545-2547.
18. Chen YL, Wright C, Pietropaoli AP, et al. Right ventricular dysfunctionis superior and sufficient for risk stratification by a pulmonaryembolism response team. J Thromb Thrombolysis. 2020;49(1):34-41.
19. Bulkley GB. The role of oxygen free radicals in human diseaseprocesses. Surgery. 1983;94(3):407-411.
20. Pradeep H, Diya JB, Shashikumar S, Rajanikant GK. Oxidative stress--assassin behind the ischemic stroke. Folia Neuropathol. 2012;50(3):219-230.
21. Özkul A, Akyol A, Yenisey C, Arpacı E, Kıylıoğlu N, TataroğluC. Oxidative stress in acute ischemic stroke. J Clin Neurosci.2007;14(11):1062-1066.
22. Aykal G, Güven R, Yeğin A, Ellidağ HY, Bayindir A, Yilmaz N. Thediagnostic value of oxidative/antioxidative balance parameters invenous thromboembolism. Clin Lab. 2015;61(7):769-775.
23. Batmaz E, Edis Çakır E, Eskiocak S, Hatipoğlu ON, Kaya S. Thediagnostic value of oxidative stress products in pulmonary embolism.Turk Thorac J. 2011;12(3):100-104.
24. Halıcı B, Sarınç Ulaşlı S, Günay E, et al. Assessment of inflammatorybiomarkers and oxidative stress in pulmonary thromboembolism:follow-up results. Inflammation. 2014;37(4):1186-1190.
25. Reis GS, Augusto VS, Silveira AP, et al. Oxidative-stress biomarkers inpatients with pulmonary hypertension. Pulm Circ. 2013;3(4):856-861.
26. Smukowska-Gorynia A, Rzymski P, Marcinkowska J, et al. Prognosticvalue of oxidative stress markers in patients with pulmonary arterialor chronic thromboembolic pulmonary hypertension. Oxid Med CellLongev. 2019;3795320.
27. Morris TA. Why acute pulmonary embolism becomes chronicthromboembolic pulmonary hypertension: clinical and geneticinsights. Curr Opin Pulm Med. 2013;19(5):422-429.